Whereas Droxidopa is a drug used to treat non-diabetic autonomic neuropathy, primary autonomic failure, and symptomatic neurogenic orthostatic hypotension (nOH) brought on by dopamine beta-hydroxylase deficiency. Here, DBH is linked to diabetic autonomic neuropathy.